ITL HEALTH GROUP LIMITED overview

ITL BioMedical Launches "ITL Clinical", a New Brand to Target Hospital and Clinical Markets PR Newswire MELBOURNE, Australia, Nov. 14, 2017 MELBOURNE, Australia , Nov. 14, 2017 /PRNewswire/ -- ITL BioMedical , a division of ITL Health Group (ASX: ITD), that creates and manufacturers leading edge medical devices for the clinical, blood banking and laboratory markets, is pleased to announce the launch of a new global brand, ITL Clinical, that will feature ITL products that serve the hospital and...

ITL Limited Rebrands to ITL Health Group to Unify Divisions under a Global Brand PR Newswire MELBOURNE, Australia, Feb. 28, 2017 MELBOURNE, Australia , Feb. 28, 2017 /PRNewswire/ -- ITL Limited ( ASX:ITD ), an innovative global medical technology company, supplier and strategic partner that provides innovative products and solutions to healthcare markets and empowers individual health management, formally announces its rebrand to ITL Health Group (ITL). The name change is part of the Company's...

ITL Profit Doubles In Half Year 2016/2017 Results PR Newswire MELBOURNE, Australia, Feb. 24, 2017 MELBOURNE, Australia , Feb. 24, 2017 /PRNewswire/ -- ITL Limited, ( ASX: ITD ), an innovative diversified healthcare company, is pleased to announce excellent results for the half year ended 31 December 2016 compared with the previous corresponding period. A full "Results and ITL BioMedical Growth Update" presentation can be viewed here . Highlights Profit after tax of $2.12m ( Dec 2015 : $1.04m ;...

ITL Profit Doubles In Half Year 2016/2017 Results PR Newswire MELBOURNE, Australia, Feb. 23, 2017 MELBOURNE, Australia , Feb. 23, 2017 /PRNewswire/ -- ITL Limited, ( ASX: ITD ), an innovative diversified healthcare company, is pleased to announce excellent results for the half year ended 31 December 2016 compared with the previous corresponding period. A full "Results and ITL BioMedical Growth Update" presentation can be viewed here . Highlights Profit after tax of $2.12m ( Dec 2015 : $1.04m ;...

ITL Profit Doubles In Half Year 2016/2017 Results PR Newswire MELBOURNE, Australia, Feb. 23, 2017 MELBOURNE, Australia , Feb. 23, 2017 /PRNewswire/ -- ITL Limited, ( ASX: ITD ), an innovative diversified healthcare company, is pleased to announce excellent results for the half year ended 31 December 2016 compared with the previous corresponding period. A full "Results and ITL BioMedical Growth Update" presentation can be viewed here . Highlights Profit after tax of $2.12m ( Dec 2015 : $1.04m ;...

KINGSPORT, Tenn., Feb. 14, 2017 (GLOBE NEWSWIRE) -- ITL Pharma, Inc. (ITL), a LIAS Research Company, today announced awarding of a United States Patent (US 9,526,701) titled: "Sustained Drug Release and Improved Product Stability Using Non-Covalent Particle Coating Methods." This "umbrella" patent provides a novel approach to drug delivery, allowing for extended product stability and controlled release of the API. TriThroid® (T3, Liothyronine, Na) is the lead product in the pipeline of products...

ITL BioMedical Announces Early Sales of Recently Launched New Product DonorCare® Needle Guard 2 PR Newswire MELBOURNE, Australia, Nov. 16, 2016 MELBOURNE, Australia , Nov. 16, 2016 /PRNewswire/ -- ITL BioMedical , a division of ITL (ASX: ITD) that sets industry standards for the innovative design and production of biological sampling systems for human and animal use, is pleased to announce that after launching its highly innovative patented DonorCare Needle Guard 2 mid-October the Company has...

ITL BioMedical Announces Global Launch of DonorCare® Needle Guard 2 PR Newswire MELBOURNE, Australia, Nov. 8, 2016 MELBOURNE, Australia , Nov. 8, 2016 /PRNewswire/ -- ITL BioMedical , a division of ITL that sets industry standards for the innovative design and production of biological sampling systems for human and animal use, is pleased to announce the global launch of its highly innovative patented DonorCare Needle Guard 2 that took place at the American Association of Blood Banks (AABB)...